Alkahest Scientific Founder Tony Wyss-Coray Recognized as One of TIME Magazine's 50 Most Influential People in Health Care

Friday, November 2, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

SAN CARLOS, Calif., Nov. 2, 2018 /PRNewswire/ -- Alkahest Inc. ("Alkahest"), a clinical-stage biotechnology company focused

on developing innovative therapies to treat age-related diseases, announced today that Tony Wyss-Coray Ph.D., Alkahest's co-founder and board member was named to TIME Health's list of individuals who were most influential in transforming healthcare in
2018.  

"Time Magazine's 'Health Care 50' highlights those who have significantly changed the state of U.S. health care this year and we are pleased to see this recognition for Tony's pioneering work in understanding the role of the plasma proteome in age-related diseases," said Karoly Nikolich, Ph.D., Alkahest's co-founder and chief executive officer.

Professor Wyss-Coray received his Ph.D. from the University of Berne, Switzerland and joined Stanford University's faculty in 2002, where he now serves as a professor of neurology and neurological sciences. He is also the co-director of Stanford Alzheimer's Disease Research Center and associate director of the Center for Tissue Regeneration, Repair and Restoration at the Palo Alto VA. His lab investigates the role of immune responses in brain aging and neurodegeneration with a focus on cognitive decline and Alzheimer's disease. Together with Dr. Karoly Nikolich, Professor Wyss-Coray established Alkahest in 2014 to translate his pioneering research into innovative medicines that can help patients with age-related diseases. 

About Alkahest Alkahest is a privately-held clinical-stage company based in the San Francisco Bay Area developing treatments for age-related diseases, with an emphasis on neurodegeneration — a key medical challenge for our generation. The company's breakthrough research has elucidated changes in the plasma proteome in healthy aging and age-related diseases, and demonstrated that factors in the blood plasma can be augmented or inhibited in order to reverse detrimental effects of aging in both normal aging and disease models in animals. Alkahest is developing novel plasma-based therapies in collaboration with Barcelona, Spain-based Grifols, a global healthcare company and leading producer of plasma therapies.  For further information see www.alkahest.com.

Contact Information:

Joe McCrackenVice President Business DevelopmentAlkahest, Inc. jmccracken@alkahest.com

Media Contact:Michael TattoryLifeSci Public Relations mtattory@lifescipublicrelations.com

 

Cision View original content:http://www.prnewswire.com/news-releases/alkahest-scientific-founder-tony-wyss-coray-recognized-as-one-of-time-magazines-50-most-influential-people-in-health-care-300742859.html

SOURCE Alkahest Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store